Drug
Ergoloid Mesylates
Ergoloid Mesylates: highest development phase Approved, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| DEAPRIL-ST | Approved |
Latest
No recent events.
Follow Ergoloid Mesylates on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.